Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc > US delta variant could become dominant as vacc rate Drop

<< Previous

Bullboard Posts

Next >>

Comment by dart321on Jun 09, 2021 3:34pm

126 Views

Post# 33356662

RE:RE:RE: US delta variant could become dominant as vacc rate Drop

Today is the end of the sixth week, It only makes sense they could release the results at anytime, their published time frame was 4 to 10 weeks. In my opinion with the information I have it's going to be well before the tenth week. Luck all stay safe.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China